Table 4.
Prevalence of reactive serum samples from patients with different clinical forms of Chagas disease*
| Antigens | ChD (N = 228) | IC (N = 58) | DC (N = 59) | MCC (N = 57) | SCC (N = 54) |
|---|---|---|---|---|---|
| N (%) | N (%) | N (%) | N (%) | N (%) | |
| Trypanosoma cruzi | 227 (99.6) | 57 (98.2) | 59 (100) | 57 (100) | 54 (100) |
| JL7 | 217 (95.2) | 54 (93.1) | 56 (94.9) | 54 (94.7) | 53 (98.1) |
| P013 | 188 (82.5) | 49 (84.5) | 48 (81.3) | 45 (78.9) | 46 (85.2) |
| R13 | 140 (61.4) | 35 (60.3) | 36 (61.0) | 35 (61.4) | 34 (63.0) |
| JL18 | 85 (37.3) | 19 (32.8) | 14 (23.7) | 26 (45.6) | 26 (48.1) |
| JL19 | 92 (40.4) | 22 (37.9) | 16 (27.1) | 30 (52.6) | 24 (44.4) |
| P0β | 65 (28.5) | 16 (27.6) | 18 (30.5) | 9 (15.8) | 22 (40.7) |
ChD = Chagas disease; IC = indeterminate form of Chagas disease; DC = digestive form of Chagas disease; MCC = mild chagasic cardiomyopathy; SCC = severe chagasic cardiomyopathy; N = number of individuals.